STAT Plus: California supports an attorney’s unusual whistleblower lawsuit against ‘fraudulent’ patents
The California insurance commissioner is supporting an unusual gambit by a patent attorney who filed…
Category: legal
STAT Plus: States file a third lawsuit accusing dozens of generic drug makers of price fixing
An ongoing probe by numerous states widened with a new lawsuit accusing more than two…
STAT Plus: A judge rules AbbVie isn’t ‘immunized’ from antitrust claims over its Humira patent dealings
In a victory for AbbVie (ABBV), a U.S. federal judge ruled the drug maker did…
STAT Plus: Judge rules AbbVie didn’t unfairly thwart Humira competition with its ‘patent thicket’
In a victory for AbbVie (ABBV), a U.S. federal judge ruled the drug maker did…
STAT Plus: Pharmalittle: Will AstraZeneca bid for Gilead?; university terminates researcher over Covid-19 papers
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT Plus: Will the ‘patent dance’ cause Amgen to temporarily pull a biosimilar off the market?
In a closely watched case, a federal appeals court must decide whether a biosimilar company…
STAT Plus: Inovio sues a key contract manufacturer as it races to develop a Covid-19 vaccine
As the race to develop a Covid-19 vaccine accelerates, Inovio Pharmaceuticals (INO) filed a lawsuit…
STAT Plus: Pharmalittle: Glaxo aims for 1 billion doses of a Covid-19 vaccine booster; Pence aide holds lots of pharma stocks
Rise and shine, everyone, another busy day is on the way. We can tell because…
STAT Plus: In a tale of two Mercks, the German company wins a court battle over its U.S. rival
In a setback for Merck (MRK), a court in London ruled that the big drug…
STAT Plus: Pharmalittle: Experts say wait-and-see about Moderna’s Covid-19 vaccine; J&J will stop selling talc products in the U.S.
Hello, everyone, and welcome to the middle of the week. Time flies when you are…
STAT Plus: Pharmalittle: FDA rejects drug from Bristol and Bluebird; Gilead signs deals to widen access to remdesivir
Rise and shine, everyone, another busy day is on the way. Although the days may…
STAT Plus: Pharmalittle: Birx acknowledges remdesivir distribution was flawed; Moderna gets FDA fast track for Covid-19 vaccine
Top of the morning to you, and a fine one it is. Despite the doom…
Opinion: Acknowledging the public role in private drug development: lessons from remdesivir
The quest for vaccines and therapeutic treatments against Covid-19 shouldn’t be complicated or delayed by…
STAT Plus: Apotex to pay $24 million to settle price fixing charges stemming from long-running probe
In the latest fallout from a federal probe into generic drug price fixing, Apotex agreed…
STAT Plus: Gilead sues U.S., claiming it ‘secretly’ obtained patents on HIV research that led to Truvada
Gilead Sciences (GILD) has accused the U.S. government of breaching several contracts and “secretly” obtaining…
Opinion: De-identified data exception in HIPAA poses a litigation risk
As money pours into health care startups built around artificial intelligence — more than 350 deals…
STAT Plus: Pharmacy chains gain a ‘solid’ victory in opioid litigation, but aren’t off the hook yet
As jockeying in the opioid litigation continues, a U.S. appeals court ruled several large pharmacy…
Coronavirus pandemic will delay the blockbuster trial of ex-Theranos CEO Elizabeth Holmes
It was supposed to be the blockbuster courtroom drama of summer 2020: former Theranos CEO…
.jpg)
Opinion: The tension between public health and patents in the era of Covid-19
The Covid-19 pandemic, devastating as it is, is producing some triumphs of collaborative research and…
Opinion: Invoking Bayh-Dole may be needed to get affordable Covid-19 treatments
As the Covid-19 pandemic strains the capacity of the U.S. health care system, attention is…
Opinion: Biosimilars could disappear if the Supreme Court overturns the ACA
With the sense of urgency rightly focused on slowing or stopping the spread of Covid-19,…
Roche backpedals and agrees to provide a solution for Covid-19 tests in the Netherlands
In a startling about-face, Roche (RHHBY) has agreed to release the recipe for a liquid…
STAT Plus: AbbVie waives all worldwide restrictions on making generic copies of its Kaletra HIV pill
In an unexpected development, AbbVie (ABBV) is waiving restrictions on licenses held by a nonprofit…
AbbVie will allow generic copies of its HIV pill in Israel after the government approved a license
After the Israeli government approved licensing for a generic copy of the Kaletra HIV pill…
STAT Plus: Novartis is scolded by Finnish regulators over hospital sales of a migraine drug
Regulators in Finland threatened to fine Novartis (NVS) for violating laws governing the distribution of…
Opinion: Data analysts: a new kind of whistleblower to ‘catch a rogue’?
Most whistleblower cases, regardless of industry, emerge through the bravery and integrity of an employee…
Opinion: Can you sue an algorithm for malpractice? It depends
The rapid entry of artificial intelligence is stretching the boundaries of medicine. It will also…
Opinion: Trump’s immigration policies will make the coronavirus pandemic worse
Pandemics have a way of testing us. Throughout history, societies have responded to plagues by…
Justice Department sues Mallinckrodt over ‘hundreds of millions of dollars’ in Medicaid rebates
A simmering feud between the federal government and Mallinckrodt (MNK) took a new turn as…
STAT Plus: Contract spells out how the University of Chicago shared patient data with Google
SAN FRANCISCO — In December 2016, Google and the University of Chicago signed a contract…
STAT Plus: Novartis employee claims she was fired for complaining about incorrect data
As Novartis (NVS) geared up to win approval for a new eye medication that was…
STAT Plus: Contract offers unprecedented look at Google deal to obtain patient data from the University of California
SAN FRANCISCO — It was the fall of 2015 when researchers from Google and the…
Federal judge rules clinical trial sponsors must publish a decade’s worth of missing data
WASHINGTON — For years, government research agencies have misinterpreted a law that requires them to…
STAT Plus: Alkermes sued over death of man who overdosed after taking addiction treatment Vivitrol
The parents of a 26-year-old California man who died of an opioid overdose have sued…
STAT Plus: Gilead loses another challenge to a pair of U.S. patents for an HIV prevention pill
For the second time this month, Gilead Sciences (GILD) has lost a bid to invalidate…
STAT Plus: Biotech founder who said his painkiller would replace opioids sentenced to 7 years in prison
The founder of a biotech who said his company had developed a painkiller that would…
STAT Plus: Pharmalittle: Coronavirus clinical trials are going slower than hoped; opioid lawsuit payouts may be less than expected
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT Plus: U.S. officials lash out at the Dutch government for moves that ‘undermine’ pharma patent rights
In an unusual move, the U.S. Embassy in the Netherlands is taking the Dutch government…
STAT Plus: Gilead loses its challenge to a pair of U.S. patents over an HIV prevention pill
In a setback to Gilead Sciences (GILD), a federal panel rejected its bid to invalidate…
STAT Plus: A former Taro Pharma executive is indicted in generic price-fixing probe
A former senior executive at Taro Pharmaceuticals USA was indicted for his role in a…
STAT Plus: Prosecutors identified ‘Pharma Co. X’ as central to alleged opioid kickback scheme. Was it Purdue?
Federal prosecutors this week announced a $145 million settlement with an electronic health records company…
Top Harvard chemist charged with lying about ties to Chinese government program
The head of Harvard University’s chemistry department was charged on Tuesday with attempting to conceal…
Martin Shkreli is sued by the FTC and NY attorney general for illegally cornering a market
More than four years after Martin Shkreli incensed Americans by raising the price of a…
STAT Plus: McKesson reaches $175 million deal with shareholders over lax oversight of opioid shipments
As pressure mounts on pharmaceutical wholesalers over their role in the opioid crisis, McKesson (MCK)…
STAT Plus: McKesson reaches $175 million deal with shareholders over lax oversight of opioid shipments
As pressure mounts on pharmaceutical wholesalers over their role in the opioid crisis, McKesson (MCK)…
STAT Plus: Roche is fined by Romania for thwarting competition to its cancer medicines
Following a two-year investigation, Roche (RHHBY) was fined $14 million by antitrust authorities in Romania…
STAT Plus: Another patient charity settles charges it helped drug makers pay Medicare kickbacks
After a contentious, two-year battle with federal authorities, a patient charity called Patient Services agreed…
STAT Plus: Insys founder gets 5½ years in jail for his role in fentanyl prescription scheme
The founder of Insys Therapeutics was sentenced to 5½ years in federal prison Thursday for…
STAT Plus: Former Insys executive who dressed as giant fentanyl bottle gets 26-month sentence
A former high-ranking Insys Therapeutics executive who dressed as a giant fentanyl spray bottle in…
STAT Plus: Former Insys executive sentenced to a year and a day for her role in opioid bribery scheme
A former pharmaceutical executive and one-time stripper was sentenced to a year and a day…